ZERO WORLD RESEARCHアミノ酸・有機酸の学術文献データベース

Caffeine Increases Apolipoprotein A-1 and Paraoxonase-1 but not Paraoxonase-3 Protein Levels in Human-Derived Liver (HepG2) Cells.

Balkan medical journal2017Sayılan Özgün G, Özgün E, Tabakçıoğlu K, et al.
研究デザインその他の原著論文
対象ヒト

抄録

Background: Apolipoprotein A-1, paraoxonase-1 and paraoxonase-3 are antioxidant and anti-atherosclerotic structural high-density lipoprotein proteins that are mainly synthesized by the liver. No study has ever been performed to specifically examine the effects of caffeine on paraoxonase enzymes and on liver apolipoprotein A-1 protein levels.Aims: To investigate the dose-dependent effects of caffeine on liver apolipoprotein A-1, paraoxonase-1 and paraoxonase-3 protein levels.Study design: In vitro experimental study.Methods: HepG2 cells were incubated with 0 (control), 10, 50 and 200 μM of caffeine for 24 hours. Cell viability was evaluated by 3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. Apolipoprotein A-1, paraoxonase-1 and paraoxonase-3 protein levels were measured by western blotting.Results: We observed a significant increase on apolipoprotein A-1 and paraoxonase-1 protein levels in the cells incubated with 50 µM of caffeine and a significant increase on paraoxonase-1 protein level in the cells incubated with 200 µM of caffeine.Conclusion: Our study showed that caffeine does not change paraoxonase-3 protein level, but the higher doses used in our study do cause an increase in both apolipoprotein A-1 and paraoxonase-1 protein levels in liver cells.

MeSH

Analysis of VarianceApolipoprotein A-IAryldialkylphosphataseBlotting, WesternCaffeineCell SurvivalCentral Nervous System StimulantsDose-Response Relationship, DrugHep G2 CellsHumansIn Vitro TechniquesLipoproteins, HDLLiver

DOI 10.4274/balkanmedj.2016.1217

PMID 29215336

原文・出典を見る →